Michael J. Dattoli, Arvind B. Soni, Lauren Yanthis, Jone Fay, Gregory Lawrence; Long-term outcomes for patients with radiorecurrent prostate cancer treated with salvage combination IMRT and brachytherapy, American Society of Clinical Oncology (ASCO), Genitourinary Symposium, January 2024.
Michael J. Dattoli, MD, is a board-certiﬁed radiation oncologist with decades of brachytherapy experience, having performed thousands of prostate implant procedures. Dr. Dattoli attended the
By Reggie Kumar | August 05, 2016 Researchers at the UCLA Jonsson Comprehensive Cancer Center say findings in new study will help physicians and patients
By Ellen Frankman Black men are more than twice as likely as their white counterparts to die from prostate cancer. For the full article, please
(June 10, 2014 – Sarasota, FL) This week Dattoli Cancer Center & Brachytherapy Research Institute became the first independent physician practice in the U.S. to
(June 18, 2010 – Sarasota, FL) Dattoli Cancer Center has invested in the newest color-flow Doppler ultrasound technology for its prostate cancer treatment center and
American Cancer Society: Ignorance is Bliss When it Comes to Prostate Cancer By Rick Lyke The American Cancer Society is telling men to pull up